Interaction Between Valproic Acid and Carbapenem Antibiotics

REFERENCES

• Besag F. M., Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf. 2006; 29: 95–118
   PubMed Web of Science ®Google Scholar
• Clause D., Decleire P., Vanbinst R., Soyer A., Hantson P. Pharmacokinetic interaction between valproic acid and meropenem. Intens. Care Med. 2005; 31: 1293–1294
   PubMed Web of Science ®Google Scholar
• Coves Orts F. J., Borras-Blasco J., Navarro-Ruiz A., Murcia-Lopez A., Palacios-Ortega F. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann. Pharmacotherapy 2005; 39: 533–537
   PubMed Web of Science ®Google Scholar
• De Turck B. J. G., Diltoer M. W., Cornelis P. J. W. W., Maes V., Spapen H. D. M., Camu F., Huyghens L. P. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J. Antimicrob. Chemother. 1998; 42: 563–564
   PubMed Web of Science ®Google Scholar
• Fudio S., Carcas A., Pinana E., Ortega R. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J. Clin. Pharm. Ther. 2006; 31: 393–396
   PubMed Web of Science ®Google Scholar
• Horiuchi M., Kimura M., Tokumura M., Hasebe N., Arai T., Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. Toxicology 2006; 222: 114–124
   PubMed Web of Science ®Google Scholar
• Kanou M., Saeki K., Kato T., Takahashi K., Mizutani T. Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes. Fund. Clin. Pharmacol. 2002; 16: 513–517
   PubMed Web of Science ®Google Scholar
• Kojima S., Nadai M., Kitaichi K., Wang L. I., Nabeshima T., Hasegawa T. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats. Antimicrob. Agents Chemother. 1998; 42: 3136–3140
   PubMed Web of Science ®Google Scholar
• Llinares F., Bosacoma N., Hernandez C., Climent E., Selva J., Ordovas J. P. Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics. A discussion of three cases. Farmacia Hospitalaria 2003; 27: 258–263
   PubMedGoogle Scholar
• Mallet L., Babin S., Morais J. A. Valproic acid-induced hyperammonia and thrombocytopenia in an elderly woman. Ann. Pharmacother. 2004; 38: 1643–1647
   PubMed Web of Science ®Google Scholar
• Mizutani T. PM frequencies of major CYPs in asians and caucasians. Drug Metab. Rev. 2003; 35: 99–106
   PubMed Web of Science ®Google Scholar
• Mizutani T., Hattori A. New horizon of MDR1 (P-glycoprotein) study. Drug Metab. Rev. 2005; 37: 489–510
   PubMed Web of Science ®Google Scholar
• Nacarkucuk E., Saglam H., Okan M. Meropenem decreases serum level of valproic acid. Pediatric Neurol. 2004; 31: 232–234
   PubMed Web of Science ®Google Scholar
• Nagai K., Shimizu T., Togo A., Takeya M., Yokomizo Y., Sakata Y., Matsuishi T., Kato H. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J. Antimicrob. Chemother. 1997; 39: 295–296
   PubMed Web of Science ®Google Scholar
• Nakajima Y., Mizobuchi M., Nakamura M., Takagi H., Inagaki H., Kominami G., Koike M., Yamaguchi T. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Drug Metab. Dispos. 2004; 32: 1383–1391
   PubMed Web of Science ®Google Scholar
• Negishi M., Pedersen L. G., Petrotchenko E., Shevtsov S., Gotokhov A., Kakuta Y., Pedersen L. C. Structure and function of sulfotransferases. Arch. Biochem. Biophys. 2001; 390: 149–157
   PubMed Web of Science ®Google Scholar
• Ogawa K., Yumoto R., Hamada N., Nagai J., Takano M. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes. Epilepsy Res. 2006; 71: 76–87
   PubMed Web of Science ®Google Scholar
• Omoda K., Murakami T., Yumoto R., Nagai J., Maeda Y., Kiribayashi Y., Takano M. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. J. Pharm. Sci. 2005; 94: 1685–1693
   PubMed Web of Science ®Google Scholar
• Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol. 2006; 61: 246–255
   PubMed Web of Science ®Google Scholar
• Radomynska-Pandya A., Czernik P. J., Little J. M., Battaglia E., Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 1999; 31: 817–899
   PubMed Web of Science ®Google Scholar
• Remmer H., Schoene B., Fleischmann R. A. Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab. Dispos. 1973; 1: 224–230
   PubMed Web of Science ®Google Scholar
• Sala F., Padulles N., Hidalgo F., Clemente S., Cabanas M. J., Oliveras M., Balcells J. Pharmacokinetic interaction between valproic acid and meropenem. An Pediatr (Barc) 2006; 64: 93–95
   PubMedGoogle Scholar
• Santucci M., Parmeggiani A., Riva R. Seizure worsening caused by decreased serum valproate during meropenem therapy. J. Child Neur. 2005; 20: 456–457
   PubMed Web of Science ®Google Scholar
• Torii M., Takiguchi Y., Saito F., Izumi M., Yokota M. Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats. J. Pharm. Pharmacol. 2001; 53: 823–829
   PubMed Web of Science ®Google Scholar
• Torii M., Takiguchi Y., Izumi M., Fukushima T., Yokota M. Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers. Int. J. Pharm. 2002; 233: 253–256
   PubMed Web of Science ®Google Scholar
• Usui T., Kuno T., Ueyama H., Ohkubo I., Mizutani T. Proximal HNF1 element is essential for the induction of human UDP-glucoronosyltransferase 1A1 by glucocorticoid receptor. Biochem. Pharmacol. 2006; 71: 693–701
   PubMed Web of Science ®Google Scholar
• Yamagata T., Momoi M., Murai K., Ikematsu K., Suwa K., Sakamoto K., Fujimura A. Penipenem-betamipron and decreases in serum valproic acid concentration. Ther. Drug. Monit. 1998; 20: 396–400
   PubMed Web of Science ®Google Scholar
• Yamamura N., Imura-Miyoshi K., Naganuma H., Nishimura K. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. Drug Metab. Dispos. 1999; 27: 724–730
   PubMed Web of Science ®Google Scholar
• Yamamura N., Imura-Miyoshi K., Naganuma H. Panipenem, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats. Drug. Metab. Dispos. 2000; 28: 1484–1486
   PubMed Web of Science ®Google Scholar
• Yokogawa K., Iwashita S., Kubota A., Sasaki Y., Ishizaki J., Kawahara M., Matsushita R., Kimura K., Ichimura F., Miyamoto K. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits. Pharm. Res. 2001; 18: 1320–1326
   PubMed Web of Science ®Google Scholar